Results 101 to 110 of about 62,613 (194)

Validation and Evaluation of SPP1 as a Candidate Biomarker for Disease Monitoring in Focal Segmental Glomerulosclerosis. [PDF]

Int J Nephrol Renovasc Dis
Li S, Ye Q, Tan Q, Li X, Huang J, Hu B, Yang R, Li W.   +7 more
europepmc   +1 more source

Physicians' gender and specialty in relation to adverse drug reaction reporting in Sweden. [PDF]

Eur J Clin Pharmacol
Nordvall LM, Rolander B, Larsson M, Melin L, Hägg S, Kling A.   +5 more
europepmc   +1 more source

Some Reflections on ADR

, 2000
It may be time for practitioners and theorists who have contributed quality and innovation to the ADR movement to declare victory. It also may be time to cut and run, because ADR must address some difficult issues if it is to realize its full potential.
Henry, James F.
core  

Synergistic effects of Graphene Nanoplatelets and Joncryl ADR on the mechanical and thermal properties of PLA/POM nanocomposites. [PDF]

Sci Rep
Qasem R, Piah MBM, Mulkiyan OMZ, Amran M, Salem AAA, Kamal H, Al-Shaee HAY.   +6 more
europepmc   +1 more source

Adverse event mining for Breztri and Trelegy Ellipta based on the three international pharmacovigilance databases. [PDF]

Medicine (Baltimore)
Wang J, Chen K, Yun L, Xu D.
europepmc   +1 more source

Trends in adverse drug reaction reporting by dentists: a 15-year analysis of German pharmacovigilance data. [PDF]

Clin Oral Investig
Halling F, Lutz R, Meisgeier A.
europepmc   +1 more source

EZH2 blockade reverses doxorubicin resistance by inducing metabolic vulnerability and enhancing DNA damage in breast cancer. [PDF]

Front Pharmacol
Wang X, Ding Y, Mai Y, Li R, Shao X, Chen W, Li Y, Liu L, Wang H, Liu K, Niu Y, Li J, Xu G, Zhao Y.   +13 more
europepmc   +1 more source

Adverse drug reactions associated with glycyrrhiza-containing Chinese patent medicines: a literature-based analysis of individual case reports and clinical trials. [PDF]

Ther Adv Drug Saf
Yu Z, Wu D, Xie Y, Mao L, Jiang Z, Zhen J, Zhang W.   +6 more
europepmc   +1 more source

Strengthening pharmacovigilance through patient reporting: a scoping review of awareness, barriers, and facilitators. [PDF]

J Pharm Policy Pract
Aslam A, Majid HA, Muhammad Boota N, Ghulam Mustafa A, Akhtar SS.   +4 more
europepmc   +1 more source

Keys to Successful Tip Detection-Antegrade Dissection and Re-Entry (TD-ADR): Long-Axis Bias View Selection and 6 Approaches. [PDF]

JACC Case Rep
Tanaka K, Okamura A, Yoshikawa R, Yamasaki T, Tsutsui Y, Sudou K, Nishimura Y, Watanabe S, Iwamoto M, Watanabe H.   +9 more
europepmc   +1 more source